IMPROVEDD VTE risk score: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
mNo edit summary
Line 5: Line 5:
==Overview==
==Overview==
The IMPROVEDD VTE Risk Score, which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization.<ref>{{cite journal | author=Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= TH Open |volume= 01 |issue=01 |pages= e56-e65 |doi= 10.1055/s-0037-1603929 |access-date=  }}</ref><ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
The IMPROVEDD VTE Risk Score, which incorporates [[D-dimer]] measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic [[venous thromboembolism]] (including symptomatic [[deep-vein thrombosis]], nonfatal [[pulmonary embolism]], and death related to [[venous thromboembolism]]) events in acutely ill hospitalized patients up to 77 days of hospitalization.<ref>{{cite journal | author=Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. |date=2017 |title= The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification |url= https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0037-1603929#TB17006-7 |journal= TH Open |volume= 01 |issue=01 |pages= e56-e65 |doi= 10.1055/s-0037-1603929 |access-date=  }}</ref><ref name="pmid21436241">{{cite journal| author=Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH et al.| title=Predictive and associative models to identify hospitalized medical patients at risk for VTE. | journal=Chest | year= 2011 | volume= 140 | issue= 3 | pages= 706-14 | pmid=21436241 | doi=10.1378/chest.10-1944 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21436241  }} </ref>
==IMPROVEDD VTE Risk Score ==
 
==IMPROVEDD VTE Risk Score==
 
===Historical Perspective===
===Historical Perspective===
===Purpose===
===Purpose===


===Guideline Recommendations===
 
==IMPROVEDD VTE Risk Score Calculator==
==IMPROVEDD VTE Risk Score Calculator==
Shown below is the calculator for IMPROVEDD Score for VTE (check all the boxes that apply):
Shown below is the calculator for IMPROVEDD Score for VTE (check all the boxes that apply):


{{#widget:IMPROVEDDScore}}
{{#widget:IMPROVEDDScore}}
==Interpretation==
==Interpretation==
* Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
* Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
Line 21: Line 25:
* Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
* Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
* Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days
* Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days
==Guideline Recommendations==


==See also==
==See also==

Revision as of 23:16, 29 January 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Seyedmahdi Pahlavani, M.D. [3], Anmol Pitliya, M.B.B.S. M.D.[4]

Synonyms and keywords:

Overview

The IMPROVEDD VTE Risk Score, which incorporates D-dimer measurement into the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) score, refines the prediction of symptomatic venous thromboembolism (including symptomatic deep-vein thrombosis, nonfatal pulmonary embolism, and death related to venous thromboembolism) events in acutely ill hospitalized patients up to 77 days of hospitalization.[1][2]

IMPROVEDD VTE Risk Score

Historical Perspective

Purpose

IMPROVEDD VTE Risk Score Calculator

Shown below is the calculator for IMPROVEDD Score for VTE (check all the boxes that apply):

IMPROVEDD VTE Risk Score Calculator
Variable Score
Prior episode of VTE 3
Thrombophilia 2
Paralysis of the lower extremity during the hospitalization 2
Current malignancy 2
Immobilization for at least 7 days 1
ICU or CCU admission 1
Age more than 60 years 1
D-dimer ≥2× upper limit of normal (or ≥1.0 μg/mL) 2
IMPROVEDD Score:
Predicted Risk of Symptomatic VTE:

Interpretation

  • Score = 0: Predicted Risk of Symptomatic VTE is 0.4% at 35-42 days and 0.5% at 77 days
  • Score = 1: Predicted Risk of Symptomatic VTE is 0.6% at 35-42 days and 0.7% at 77 days
  • Score = 2: Predicted Risk of Symptomatic VTE is 0.8% at 35-42 days and 1.0% at 77 days
  • Score = 3: Predicted Risk of Symptomatic VTE is 1.2% at 35-42 days and 1.4% at 77 days
  • Score = 4: Predicted Risk of Symptomatic VTE is 1.6% at 35-42 days and 1.9% at 77 days
  • Score ≥ 5: Predicted Risk of Symptomatic VTE is 2.2% at 35-42 days and 2.7% at 77 days

Guideline Recommendations

See also

References

  1. ↑ Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, Hernandez AF, Korjian S, Daaboul Y, Gold A, Harrington RA, Chi G. (2017). "The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification". TH Open. 01 (01): e56–e65. doi:10.1055/s-0037-1603929.
  2. ↑ Spyropoulos AC, Anderson FA, Fitzgerald G, Decousus H, Pini M, Chong BH; et al. (2011). "Predictive and associative models to identify hospitalized medical patients at risk for VTE". Chest. 140 (3): 706–14. doi:10.1378/chest.10-1944. PMID 21436241.
Retrieved from "https://www.wikidoc.org/index.php?title=IMPROVEDD_VTE_risk_score&oldid=1543233"